
Michelle M. Iacoletti
Examiner (ID: 9693, Phone: (571)270-5789 , Office: P/2882 )
| Most Active Art Unit | 2882 |
| Art Unit(s) | 2882, 4185, 4100, 2877 |
| Total Applications | 628 |
| Issued Applications | 540 |
| Pending Applications | 11 |
| Abandoned Applications | 82 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18636186
[patent_doc_number] => 11760771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Ruthenium compound, raw material for forming thin film, and method for producing thin film
[patent_app_type] => utility
[patent_app_number] => 16/760171
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 7932
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760171 | Ruthenium compound, raw material for forming thin film, and method for producing thin film | Jul 26, 2018 | Issued |
Array
(
[id] => 16718649
[patent_doc_number] => 20210085796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/634242
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/634242 | ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME | Jul 26, 2018 | Abandoned |
Array
(
[id] => 16204806
[patent_doc_number] => 20200237796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => MEDICATION FOR INHIBITING DNA-PKCS
[patent_app_type] => utility
[patent_app_number] => 16/635006
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635006
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635006 | MEDICATION FOR INHIBITING DNA-PKCS | Jul 26, 2018 | Abandoned |
Array
(
[id] => 18216356
[patent_doc_number] => 11591277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Photochemical separations and compositions
[patent_app_type] => utility
[patent_app_number] => 16/631574
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 5307
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631574
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631574 | Photochemical separations and compositions | Jul 19, 2018 | Issued |
Array
(
[id] => 16970524
[patent_doc_number] => 11066485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Modified starch
[patent_app_type] => utility
[patent_app_number] => 16/628552
[patent_app_country] => US
[patent_app_date] => 2018-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 14965
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628552
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628552 | Modified starch | Jul 8, 2018 | Issued |
Array
(
[id] => 15342573
[patent_doc_number] => 20200009178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => Mecobalamin for Relieving Emergency Drug Poisoning
[patent_app_type] => utility
[patent_app_number] => 16/028469
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028469 | Mecobalamin for Relieving Emergency Drug Poisoning | Jul 5, 2018 | Abandoned |
Array
(
[id] => 13777711
[patent_doc_number] => 20190002394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/024283
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16024283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/024283 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF | Jun 28, 2018 | Abandoned |
Array
(
[id] => 17266368
[patent_doc_number] => 11191772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Use
[patent_app_type] => utility
[patent_app_number] => 16/628797
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5619
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628797 | Use | Jun 27, 2018 | Issued |
Array
(
[id] => 18716563
[patent_doc_number] => 11793886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Hydrophilic linkers and conjugates thereof
[patent_app_type] => utility
[patent_app_number] => 16/623226
[patent_app_country] => US
[patent_app_date] => 2018-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25970
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16623226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/623226 | Hydrophilic linkers and conjugates thereof | Jun 19, 2018 | Issued |
Array
(
[id] => 15797019
[patent_doc_number] => 20200121652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT
[patent_app_type] => utility
[patent_app_number] => 16/621871
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16621871
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/621871 | COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT | Jun 14, 2018 | Abandoned |
Array
(
[id] => 16589250
[patent_doc_number] => 10898492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Treating hearing loss
[patent_app_type] => utility
[patent_app_number] => 16/007586
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13657
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16007586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/007586 | Treating hearing loss | Jun 12, 2018 | Issued |
Array
(
[id] => 15895409
[patent_doc_number] => 20200147223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => POLYMERIC PASTE COMPOSITIONS FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/619427
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619427
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619427 | Polymeric paste compositions for drug delivery | Jun 12, 2018 | Issued |
Array
(
[id] => 13504489
[patent_doc_number] => 20180303787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => PHARMACEUTICAL USE OF 3-BENZYLSULFONYLPROPIONITRILE
[patent_app_type] => utility
[patent_app_number] => 16/007858
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16007858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/007858 | Pharmaceutical use of 3-benzylsulfonylpropionitrile | Jun 12, 2018 | Issued |
Array
(
[id] => 13589875
[patent_doc_number] => 20180346486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => NOVEL HETEROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/002007
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16002007
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/002007 | Heterocyclic compounds | Jun 6, 2018 | Issued |
Array
(
[id] => 13457937
[patent_doc_number] => 20180280511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => Continudihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods
[patent_app_type] => utility
[patent_app_number] => 16/000965
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000965
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000965 | Continudihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods | Jun 5, 2018 | Abandoned |
Array
(
[id] => 16761022
[patent_doc_number] => 20210106603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => INDUCTION OF SYNTHETIC LETHALITY WITH EPIGENETIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/618845
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618845
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618845 | Induction of synthetic lethality with epigenetic therapy | Jun 5, 2018 | Issued |
Array
(
[id] => 16009169
[patent_doc_number] => 20200179427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => DOSING SCHEDULE FOR TESETAXEL AND CAPECITABINE
[patent_app_type] => utility
[patent_app_number] => 16/617697
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617697
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617697 | DOSING SCHEDULE FOR TESETAXEL AND CAPECITABINE | May 31, 2018 | Abandoned |
Array
(
[id] => 14518985
[patent_doc_number] => 10336739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists
[patent_app_type] => utility
[patent_app_number] => 15/990855
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43198
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990855
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990855 | 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists | May 28, 2018 | Issued |
Array
(
[id] => 15898375
[patent_doc_number] => 20200148706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => METAL ALKOXIDE COMPOUND, THIN-FILM-FORMING RAW MATERIAL AND METHOD OF PRODUCING THIN FILM
[patent_app_type] => utility
[patent_app_number] => 16/609622
[patent_app_country] => US
[patent_app_date] => 2018-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609622
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609622 | METAL ALKOXIDE COMPOUND, THIN-FILM-FORMING RAW MATERIAL AND METHOD OF PRODUCING THIN FILM | May 27, 2018 | Abandoned |
Array
(
[id] => 16870036
[patent_doc_number] => 20210163503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => OXIDIZING LIQUID MEDIA FOR CHEMICAL TRANSFORMATIONS
[patent_app_type] => utility
[patent_app_number] => 16/616604
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616604
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616604 | Oxidizing liquid media for chemical transformations | May 24, 2018 | Issued |